Product category:
Laboratory and scientific training and education
News Release from: London Technology Network
Edited by the Laboratorytalk Editorial
Team on 14 February 2008
New approaches to neurodegenerative
disorders
Networking event highlighted the importance of industry and academia working together to solve R+D problems in neurodegenerative disorders such as Alzheimer's and Parkinson's disease
'Neurodegenerative Disorders: Addressing the latest developments in stem cell therapy, imaging and drug development' drew representatives from top-level researchers and pharmaceutical firms to the Institute of Physics, for an evening of presentations and networking Held on 6 February 2008, the event centred around a key problem: the lack of a treatment that reverses neurodegeneration in its disease progression
This article was originally published on Laboratorytalk on 3 Oct 2006 at 8.00am (UK)
Related stories
Advancements in pain management on show in London
It is estimated that one in seven people in the UK suffer from chronic pain, and the event focused on the latest pharmacology and imaging technology initiatives in chronic and acute pain relief
Tagging technologies beyond RFID discussed
The very latest technologies in the field of tagging and traceability were on display at London Technology Network's (LTN) latest event, held at the CASS Business School
Neurodegenerative disorders are becoming increasingly prevalent due to prolonged life expectancies, with one in five people likely to develop the illness in their 80s.
It has become imperative to find better ways of diagnosing the diseases earlier to slow its progression to a manageable level.
Speaker professor Jack Price of King's College London outlined his exciting work using stem cells, which can now be used as a laboratory tool for screening potential drugs.
Nicola Sibson of the University of Oxford revealed encouraging results from animal imaging in which a much earlier diagnosis was possible, with potential application in human subjects.
Eli Lilly's Philip Szekeres and GlaxoSmithKline's Jill Richardson outlined the latest strategies in drug discovery and development.
Networking was held among technology displays from universities across London, the east and south-east of England, although it was research from the University of Oxford which attracted the most attention: with a unique way of treating Alzheimer's using stem cells.
• London Technology Network: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
